Carter Bankshares (CARE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net income for Q2 2024 was $4.8M ($0.21 EPS), down from $5.7M in Q2 2023, mainly due to a large nonperforming loan (NPL) placed on nonaccrual in Q2 2023.
Total assets reached $4.5B at June 30, 2024, with 65 branches and loan growth led by commercial real estate.
The company remains well-capitalized, with a Tier 1 capital ratio of 10.95% and a leverage ratio of 9.43%.
Legal settlement with the Justice Entities resulted in curtailment payments and a structured payoff plan for the large NPL, reducing nonperforming loans by $7.8M in Q2 2024.
Focus on operational efficiency, technology investment, and deepening customer relationships.
Financial highlights
Net interest income for Q2 2024 was $28.1M, up 5.2% year-over-year; noninterest income rose 10% to $5.5M.
Noninterest expense increased 7.5% to $27.4M, driven by FDIC insurance and salaries.
Loans grew 6.6% year-over-year to $3.55B; deposits up 8.4% year-over-year to $3.88B.
Provision for credit losses was $0.5M for Q2 2024, up $0.4M year-over-year, reflecting loan growth and new individually evaluated loans.
Diluted EPS for Q2 2024 was $0.21, down 16.0% sequentially and 12.5% year-over-year.
Outlook and guidance
Management expects moderate loan growth and stabilization in funding costs and net interest margin in coming quarters.
Strategic focus on organic growth, operational leverage through technology, and opportunistic acquisitions.
Deposit growth is expected to remain modest, with funding cost pressures stabilizing.
Latest events from Carter Bankshares
- Net income and assets grew in 2025, with strong capital, liquidity, and improved margins.CARE
Q4 20255 Feb 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG efforts.CARE
Proxy Filing2 Dec 2025 - Loan and net interest income growth offset by asset quality pressures from a large nonaccrual loan.CARE
Q3 202521 Nov 2025 - Earnings rose on higher net interest income and loan growth, with strong capital and liquidity.CARE
Q2 20254 Aug 2025 - Q3 net income increased, margins improved, and major litigation was resolved.CARE
Q3 202413 Jun 2025 - Q1 2025 net income surged 55% year-over-year, with strong capital and loan growth.CARE
Q1 20256 Jun 2025 - Q4 net income up, asset quality improved, but large nonperforming loan still weighs on results.CARE
Q4 20245 Jun 2025